Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.37 (
DNA methyltransferase
)
4,983
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microarrays were done on the livers of mice fed
DDC
for 10 weeks, withdrawn 1 month (
DDC
primed livers) and refed 6 days, and compared with mice fed the control diet. The expression of a large number of genes changed when
DDC
was fed or refed. A Venn diagram analysis identified 649 genes where gene expression was changed in the same direction. The epigenetic memory of the
DDC
primed liver involved an increase in the expression of ubiquitin D, alpha fetoprotein, connective tissue growth factor, integrin beta 2, DNA methyl transferase 3a and DNA damage-inducible 45 gamma. DNA methyl transferase 3b was down-regulated as was Cbp/p300. When
DDC
was refed,
DNA methyltransferase
and histone deacetylase were up-regulated as shown by microarray analysis. Histone3 lysine9 acetylation was increased by
DDC
and
DDC
refeeding and DNA methyltransferases were not changed as shown by Western blot analysis. The data suggest the concept that the epigenetic memory that explains why
DDC
primed hepatocytes form MBs in 7 days of
DDC
refeeding is primarily the result of epigenetic modifications of gene expression through changes in histone acetylation and methylation, as well as DNA methylation.
...
PMID:Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. 1753 72